Expansion Momentum Pion has actively expanded through acquisitions including Two Square Science and BEE International in 2022, broadening capabilities in sample preparation, homogenization, and remote monitoring. This indicates potential added demand for integration services, cross-sell of instruments, and post-merger support packages.

In Vitro Expertise Specialized in vitro instrumentation and services for drug development, including dissolution, phys chem analysis, and in vivo prediction, present opportunities to upsell complementary analytical modules, maintenance contracts, and assay outsourcing to customers seeking end-to-end solutions.

Laboratory Services Flexible engagement models allow clients to either purchase instruments or contract Pion’s laboratories for screens, assays, and analyses. This creates a cross-sell path to laboratory services for prospective customers with project-based needs.

Subcutaneous Focus Introduction of the Subcutaneous Injection Site Simulator and SCISSOR line signals growing interest in in vitro models for biologics and subcutaneous formulations, suggesting sales opportunities for integrated systems tied to formulation development and release testing.

Digital & Data Adoption of analytics and CRM/ERP tooling (MATLAB, Power BI, Tableau, iCIMS, NetSuite) indicates data-driven sales strategies and potential for offering analytics dashboards, instrument health monitoring, and performance insights as value-added services to customers.